Yigal Nochomovitz
Stock Analyst at Citigroup
(3.18)
# 1,175
Out of 5,050 analysts
322
Total ratings
42.19%
Success rate
2.29%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Maintains: Buy | $16 → $14 | $4.06 | +244.83% | 2 | Nov 5, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $166 → $198 | $197.93 | +0.04% | 7 | Nov 4, 2025 | |
| ARDX Ardelyx | Maintains: Buy | $10 → $11 | $5.59 | +96.78% | 16 | Nov 3, 2025 | |
| CRBU Caribou Biosciences | Maintains: Buy | $5 → $8 | $2.09 | +282.78% | 6 | Nov 3, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $52 → $45 | $19.26 | +133.64% | 18 | Oct 31, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $54 → $56 | $19.31 | +190.01% | 9 | Oct 29, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $175 → $203 | $152.37 | +33.23% | 2 | Oct 29, 2025 | |
| ZBIO Zenas BioPharma | Maintains: Buy | $27 → $46 | $33.61 | +36.86% | 2 | Oct 28, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Downgrades: Neutral | $49 → $12 | $8.72 | +37.61% | 7 | Oct 23, 2025 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Buy | $33 | $22.57 | +46.21% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $18.18 | +120.02% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $97 | $95.23 | +1.86% | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $33 | $18.05 | +82.88% | 3 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $8.35 | +151.50% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $21.90 | +215.07% | 9 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7 | $1.37 | +410.95% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $16.46 | +33.66% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.2 → $1.9 | $1.25 | +52.00% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $51 | $15.04 | +239.10% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $22.97 | +126.38% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $17.63 | -60.29% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.89 | +211.42% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9.5 | $10.63 | -10.63% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $35.19 | +56.29% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $5.04 | +396.03% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $55.12 | +48.77% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $11.21 | +194.38% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.85 | +841.18% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $1.98 | +1.01% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $30.24 | +91.80% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.37 | +921.90% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.32 | -9.09% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $12.35 | +13.36% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.22 | -9.91% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $4.69 | +70.58% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $5.07 | -80.28% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $11.81 | +196.36% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $30.63 | +334.21% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $3.19 | +401.57% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.07 | +834.58% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.78 | +575.98% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.99 | - | 14 | Sep 28, 2021 |
Solid Biosciences
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $4.06
Upside: +244.83%
Krystal Biotech
Nov 4, 2025
Maintains: Neutral
Price Target: $166 → $198
Current: $197.93
Upside: +0.04%
Ardelyx
Nov 3, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $5.59
Upside: +96.78%
Caribou Biosciences
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $2.09
Upside: +282.78%
Apellis Pharmaceuticals
Oct 31, 2025
Maintains: Buy
Price Target: $52 → $45
Current: $19.26
Upside: +133.64%
Arcus Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $54 → $56
Current: $19.31
Upside: +190.01%
Neurocrine Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $175 → $203
Current: $152.37
Upside: +33.23%
Zenas BioPharma
Oct 28, 2025
Maintains: Buy
Price Target: $27 → $46
Current: $33.61
Upside: +36.86%
Arcturus Therapeutics Holdings
Oct 23, 2025
Downgrades: Neutral
Price Target: $49 → $12
Current: $8.72
Upside: +37.61%
ACADIA Pharmaceuticals
Oct 21, 2025
Initiates: Buy
Price Target: $33
Current: $22.57
Upside: +46.21%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $18.18
Upside: +120.02%
Sep 29, 2025
Downgrades: Neutral
Price Target: $101 → $97
Current: $95.23
Upside: +1.86%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $18.05
Upside: +82.88%
Aug 12, 2025
Maintains: Buy
Price Target: $20 → $21
Current: $8.35
Upside: +151.50%
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $21.90
Upside: +215.07%
Aug 11, 2025
Maintains: Buy
Price Target: $9 → $7
Current: $1.37
Upside: +410.95%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $16.46
Upside: +33.66%
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.25
Upside: +52.00%
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $15.04
Upside: +239.10%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $22.97
Upside: +126.38%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $17.63
Upside: -60.29%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.89
Upside: +211.42%
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $10.63
Upside: -10.63%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $35.19
Upside: +56.29%
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.04
Upside: +396.03%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $55.12
Upside: +48.77%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $11.21
Upside: +194.38%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.85
Upside: +841.18%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.98
Upside: +1.01%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $30.24
Upside: +91.80%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.37
Upside: +921.90%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.32
Upside: -9.09%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $12.35
Upside: +13.36%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.22
Upside: -9.91%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $4.69
Upside: +70.58%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $5.07
Upside: -80.28%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $11.81
Upside: +196.36%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $30.63
Upside: +334.21%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $3.19
Upside: +401.57%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.07
Upside: +834.58%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.78
Upside: +575.98%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.99
Upside: -